Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts: Implications for Adjuvant Treatment

Garbe, Claus; Keim, Ulrike; Amaral, Teresa; Berking, Carola; Eigentler, Thomas K.; Flatz, Lukas; Gesierich, Anja; Leiter, Ulrike; Stadler, Rudolf; Sunderkotter, Cord; Tuting, Thomas; Utikal, Jochen; Wollina, Uwe; Zimmer, Lisa; Zouboulis, Christos C.; Ascierto, Paolo A.; Eggermont, Alexander M. M.; Grob, Jean-Jacques; Hauschild, Axel; Sekulovic, Lidija Kandolf; Long, Georgina, V; Luke, Jason J.; Michielin, Olivier; Peris, Ketty; Schadendorf, Dirk; Kirkwood, John M.; Lorigan, Paul C.

Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts: Implications for Adjuvant Treatment

Autor(en):

Garbe, Claus; Keim, Ulrike; Amaral, Teresa; Berking, Carola; Eigentler, Thomas K.; Flatz, Lukas; Gesierich, Anja; Leiter, Ulrike; Stadler, Rudolf; Sunderkotter, Cord; Tuting, Thomas; Utikal, Jochen; Wollina, Uwe; Zimmer, Lisa; Zouboulis, Christos C.; Ascierto, Paolo A.; Eggermont, Alexander M. M.; Grob, Jean-Jacques; Hauschild, Axel; Sekulovic, Lidija Kandolf; Long, Georgina, V; Luke, Jason J.; Michielin, Olivier; Peris, Ketty; Schadendorf, Dirk; Kirkwood, John M.; Lorigan, Paul C.

Tübinger Autor(en):

Garbe, Claus
Keim, Ulrike
Amaral, Teresa
Flatz, Lukas
Leiter, Ulrike

Erschienen in:

Journal of Clinical Oncology (2022), Bd. 40, H. 32, S. 3741

Verlagsangabe:

Lippincott Williams & Wilkins

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1200/JCO.22.00202

ISSN:

0732-183X